This inventor holds 3 USPTO granted patents and 3 EPO patents. Top assignees: Merck Sharp + Dohme Corp., Oncotherapy Science, Incorporated, Ono Pharmaceutical Co., Ltd.. Active years: 2017-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Dover, SG (2017)
- Singapore, SG (2018 - 2019)
Company Filing History:
1 out of 2,405 
1 out of 150 
1 out of 575 Years Active: 2017-2019
Title: Anjan Chakrabarti: A Trailblazer in Pharmaceutical Innovations
Introduction
Anjan Chakrabarti is a notable inventor based in Singapore, SG, recognized for his contributions to the pharmaceutical industry. With two patents under his name, he has made significant advancements in medical science, particularly in the field of drug development.
Latest Patents
Anjan's latest patents include innovative discoveries that aim to address health challenges. The first patent is for a bicyclic compound, which is specifically designed for inhibiting SUV39H2. This invention centers around a compound represented by a distinctive formula that showcases its potential in therapeutic applications. His second patent relates to Factor XIa inhibitors, providing a compound that comprises one or more formulations for treating conditions such as thromboses, embolisms, hypercoagulability, or fibrotic changes. These compounds are characterized as selective Factor XIa inhibitors or dual inhibitors of Factor XIa and plasma kallikrein, showcasing their importance in modern medicine.
Career Highlights
Anjan Chakrabarti has garnered experience working with prestigious companies in the pharmaceutical sector. Notably, he has contributed to Merck Sharp & Dohme Corporation, where he leveraged his expertise to drive innovations in drug development. Additionally, he has worked with Oncotherapy Science, Incorporated, further establishing his role as a key player in the industry.
Collaborations
Throughout his career, Anjan has collaborated with talented individuals like Yeon-Hee Lim and Zhuyan Guo. These partnerships have played a vital role in the success of his inventions, allowing for a dynamic exchange of ideas and fostering innovation in pharmaceutical research.
Conclusion
Anjan Chakrabarti's inventive spirit and dedication to advancing medical science have made him a distinguished figure in the field of pharmaceuticals. His innovative patents and collaborative efforts highlight his commitment to improving health outcomes and position him as a prominent inventor in Singapore.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile